Back to FMR LLC FMR LLC

CRNXCRNX
7 quarters

Position history for FMR LLCFMR LLC's holdings in CRINETICS PHARMACEUTICALS IN

FMR LLC holds 15.8M shares of CRNX (CRINETICS PHARMACEUTICALS IN), worth $592.7M as of 2026-Q2. The position was increased (+0.5% shares). CRNX represents 0.0% of FMR LLC's portfolio.

Current Value

$592.7M

Current Shares

15.8M

Total Value Change

+$136.2M

Total Shares Change

+6.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
15.8M
+0.5%
$592.7M0.0%$37.42
32
2026-Q1
Increased
15.8M
+10.3%
$572.4M0.0%$36.32
35
2025-Q4
Increased
14.3M
+0.8%
$665.4M0.0%$46.55
32
2025-Q3
Increased
14.2M
+0.4%
$590.9M0.0%$41.65
32
2025-Q2
Increased
14.1M
+0.7%
$406.3M0.0%$28.76
31
2025-Q1
Increased
14M
+57.2%
$470.6M0.0%$33.54
45
2024-Q4
New
8.9M
-
$456.5M0.0%$51.13
43

Other major holders of CRNX: VANGUARD GROUP INC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used